Stock Sales

Albert Bourla, chairman and CEO of Pfizer, sold millions of dollars' worth of company stock on Monday as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.

National
Economy
Health & Safety

Pfizer CEO Sold Millions In Stock After Coronavirus Vaccine News, Raising Questions

8:32pm November 11, 2020

by Tom Dreisbach

Pfizer's CEO sold $5.6 million worth of stock on Monday. The company says the stock sale was made as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.

Queue Listen Now

Moderna, based in Cambridge, Mass., has reached phase three trials for its coronavirus vaccine. At the same time, its executives have sold tens of millions of dollars worth of stock, which has led to intense criticism of the company.

Science
Health & Safety

'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns

11:35am September 04, 2020

by Tom Dreisbach

Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.